Spasticity and Its Contribution to Hypertonia in Cerebral Palsy

Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Biomed Res Int
Prif Awduron: Bar-On, Lynn, Molenaers, Guy, Aertbeliën, Erwin, Van Campenhout, Anja, Feys, Hilde, Nuttin, Bart, Desloovere, Kaat
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2015
Pynciau:
Review Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306250/
https://ncbi.nlm.nih.gov/pubmed/25649546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317047
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg